adenosine diphosphate has been researched along with pyrazines in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (15.38) | 18.7374 |
1990's | 4 (30.77) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Reeves, ML; Rink, TJ; Simpson, AW | 1 |
Handler, JS; Orloff, J; Preston, AS | 1 |
Foks, H; Kaliszan, R; Petrusewicz, J; Pilarski, B; Turowski, M | 1 |
Foks, H; Gami-Yilinkou, R; Kaliszan, R; Petrusewicz, J; Pilarski, B | 1 |
Funaya, H; Hori, M; Kitakaze, M; Minamino, T; Mori, H; Node, K; Shinozaki, Y | 1 |
Coleman, JC; Coller, BS; Hillman, RS; Lee, TT; Lincoff, AM; Smith, JW; Steinhubl, SR | 1 |
Abe, T; Fukuuchi, Y; Inoue, K; Satoh, H; Tanahashi, N; Tomita, M; Tomita, Y | 1 |
Hsiao, G; Lee, YM; Sheu, JR; Yen, MH | 1 |
Shimomura, O; Teranishi, K | 1 |
Shan, LC; Sun, YW; Wang, YQ; Xu, CL | 1 |
Fu, L; Jiang, F; Jin, Y; Liu, J; Liu, W; Zhang, Y | 1 |
Diao, XJ; Gong, GQ; He, GW; Xu, YG; Yang, WH; Yang, XZ | 1 |
Huang, WJ; Li, JM; Liu, HC; Xie, D; Zhang, YC; Zuo, J | 1 |
13 other study(ies) available for adenosine diphosphate and pyrazines
Article | Year |
---|---|
Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.
Topics: 1-Methyl-3-isobutylxanthine; 2',3'-Cyclic-Nucleotide Phosphodiesterases; Adenosine Diphosphate; Blood Platelets; Collagen; Cyclic AMP; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Pyrazines | 1988 |
Effect of ADH, aldosterone, ouabain, and amiloride on toad bladder epithelial cells.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aldosterone; Amiloride; Animals; Biological Transport, Active; Bufo marinus; Carbon Isotopes; Creatine; Diuretics; Epithelial Cells; Epithelium; Glucose; In Vitro Techniques; Ouabain; Phosphocreatine; Pyrazines; Pyruvates; Sodium; Stimulation, Chemical; Urinary Bladder; Vasopressins | 1972 |
Comparative studies of antiplatelet activity of nonsteroidal antiinflammatory drugs and new pyrazine CH- and NH-acids.
Topics: Adenosine Diphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Collagen; Epinephrine; Fibrinolytic Agents; Humans; Indomethacin; Ketorolac; Male; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Pyrazines; Tolmetin | 1995 |
Pyrazine CH- and NH-acids. Antithrombotic activity and chromatographic behaviour.
Topics: Adenosine Diphosphate; Amides; Animals; Chromatography, High Pressure Liquid; Collagen; Fibrinolytic Agents; In Vitro Techniques; Mice; Nitriles; Pyrazines; Regression Analysis | 1993 |
Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Cardiotonic Agents; Dipyridamole; Dogs; Enzyme Activation; Enzyme Inhibitors; Infusions, Intra-Arterial; Ion Channel Gating; Myocardial Infarction; Myocardial Reperfusion Injury; Potassium Channels; Pyrazines; Quinolines; Receptors, Purinergic P1; Theophylline | 1997 |
Rapid platelet-function assay: an automated and quantitative cartridge-based method.
Topics: Abciximab; Adenosine Diphosphate; Antibodies, Monoclonal; Autoanalysis; Guanidines; Humans; Immunoglobulin Fab Fragments; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines; Radiometry; Time Factors | 1999 |
Adhesion of adenosine diphosphate-activated platelets to human brain microvascular endothelial cells under flow in vitro is mediated via GPIIb/IIIa.
Topics: Adenosine Diphosphate; Brain; Cells, Cultured; Endothelium, Vascular; Fibrinolytic Agents; Guanidines; Humans; Microcirculation; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines | 2001 |
Antithrombotic effects of tetramethylpyrazine in in vivo experiments.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Blood Pressure; Drug Evaluation, Preclinical; Fibrinolytic Agents; Injections, Intravenous; Mesenteric Arteries; Mesenteric Veins; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Pyrazines; Radiation Injuries, Experimental; Reproducibility of Results; Thrombolytic Therapy; Vasodilator Agents; Venous Thrombosis | 2001 |
Bioluminescence of the arm light organs of the luminous squid Watasenia scintillans.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animal Structures; Animals; Catalysis; Decapodiformes; Enzyme Stability; Hydrogen-Ion Concentration; Imidazoles; Kinetics; Luciferases; Luminescence; Luminescent Measurements; Magnesium Chloride; Molecular Structure; Particle Size; Photochemistry; Pyrazines; Spectrophotometry; Subcellular Fractions; Sucrose; Temperature | 2008 |
[Inhibitory effect of TBN on platelet aggregation in rabbit].
Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Drugs, Chinese Herbal; Male; Nephelometry and Turbidimetry; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Rabbits | 2010 |
Design, synthesis, and evaluation of 2-substituted ethenesulfonic acid ester derivatives as protein tyrosine phosphatase 1B inhibitors.
Topics: Adenosine Diphosphate; Animals; Benzimidazoles; Blood Platelets; Dabigatran; Drug Design; Esters; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microsomes, Liver; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrazines; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Venous Thrombosis | 2012 |
Synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing a cleavable moiety with anti-platelet activity.
Topics: Adenosine Diphosphate; Animals; Benzimidazoles; Blood Platelets; Dabigatran; Drug Design; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microsomes, Liver; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrazines; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Venous Thrombosis | 2012 |
[Synthesis and biological evaluation of novel chalcone aromatic oxygen alkyl acids compounds].
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Chalcones; Hyperlipidemias; Hypolipidemic Agents; Mice, Inbred C57BL; Oxygen; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines | 2016 |